circCUL2 regulates gastric cancer malignant transformation and cisplatin resistance by modulating autophagy activation via miR-142-3p/ROCK2

• Published in: Molecular cancer Vol. 19; no. 1; pp. 1 - 19
• Main Authors: Peng, Lei, Sang, Huaiming, Wei, Shuchun, Li, Yuanyuan, Jin, Duochen, Zhu, Xudong, Li, Xuan, Dang, Yini, Zhang, Guoxin
• Format: Journal Article
• Language: English
• Published: London BioMed Central 05.11.2020; BMC
• Subjects: Antibodies; Apoptosis; Autophagy; Cancer therapies; Cell cycle; Cell growth; Chemotherapy; circCUL2; Cisplatin; Cisplatin resistance; DNA microarrays; Fluorescence in situ hybridization; Gastric cancer; Gene expression; Genetic transformation; Hybridization; Immunofluorescence; Immunoprecipitation; Medical prognosis; miR-142-3p; Phagocytosis; Proteins; Reagents; Ribonucleic acid; RNA; ROCK2; Transmission electron microscopy; Tumor suppressor genes; Tumorigenesis; Tumorigenicity; Brazil; United States > US; China; Japan
• ISSN: 1476-4598; 1476-4598
• DOI: 10.1186/s12943-020-01270-x

Background Circular RNAs (circRNAs) are a class of noncoding RNAs (ncRNAs) and can modulate gene expression by binding to miRNAs; further, circRNAs have been shown to participate in several pathological processes. However, the expression and biological function of circCUL2 in gastric cancer (GC) remains largely unknown. Methods circRNA microarrays and quantitative real-time PCR (qRT-PCR) were used to identify differentially expressed circRNAs in GC tissues and cell lines. circCUL2 knockdown and overexpression were performed to indicate the functional role of circCUL2 in vitro and in vivo. The expression and regulation of circCUL2, miR-142-3p and ROCK2 were evaluated using fluorescence in situ hybridization (FISH), dual-luciferase assays, RNA pull-down assays, RNA immunoprecipitation (RIP) and rescue experiments. Furthermore, the regulation of cisplatin sensitivity and autophagy by circCUL2/miR-142-3p/ROCK2 was demonstrated by cellular apoptosis assays, western blot, immunofluorescence and transmission electron microscopy analyses. Results The level of circCUL2, which is stable and cytoplasmically localized, was significantly reduced in GC tissues and cells. Overexpressed circCUL2 inhibited malignant transformation in vitro and tumorigenicity in vivo. In the AGS and SGC-7901 cell lines, circCUL2 sponged miR-142-3p to regulate ROCK2, thus modulating tumor progression. Furthermore, in the AGS/DDP and SGC-7901/DDP cell lines, circCUL2 regulated cisplatin sensitivity through miR-142-3p/ROCK2-mediated autophagy activation. Conclusion circCUL2 may function as a tumor suppressor and regulator of cisplatin sensitivity through miR-142-3p/ROCK2-mediated autophagy activation, which could be a key mechanism and therapeutic target for GC.